A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Public ClinicalTrials.gov record NCT06879041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, First-in-human, Dose Escalation Study Of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Study identification
- NCT ID
- NCT06879041
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 136 participants
Conditions and interventions
Interventions
- AZD2275 Drug
- AZD2284 Drug
- AZD2287 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 9, 2025
- Primary completion
- Apr 15, 2029
- Completion
- Apr 15, 2029
- Last update posted
- May 11, 2026
2025 – 2029
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Palo Alto | California | 94304 | Not yet recruiting |
| Research Site | San Diego | California | 92103 | Not yet recruiting |
| Research Site | Miami | Florida | 33165 | Recruiting |
| Research Site | Tampa | Florida | 33612 | Recruiting |
| Research Site | Chicago | Illinois | 60637 | Recruiting |
| Research Site | Metairie | Louisiana | 70006 | Not yet recruiting |
| Research Site | Boston | Massachusetts | 02215 | Recruiting |
| Research Site | Rochester | Minnesota | 55902 | Not yet recruiting |
| Research Site | Omaha | Nebraska | 68130 | Recruiting |
| Research Site | New York | New York | 10032 | Not yet recruiting |
| Research Site | Cleveland | Ohio | 44195 | Not yet recruiting |
| Research Site | Portland | Oregon | 97239 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06879041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06879041 live on ClinicalTrials.gov.